Release date: 2024-07-08 12:08:46 Article From: Lucius Laos Recommended: 262
As 2022 draws to a close, Lucius Pharmaceutical (Laos) Co., Ltd. ushered in the inspection and training of GMP professional teams organized by the Lao national government department.
What is GMP? The GMP workshop is a well-managed style workshop. "GMP" is the abbreviation of Good Manufacturing Practice in English, GMP means "Good Manufacturing Practice" or "Good Manufacturing Practice" in Chinese, and is an independent management system that pays special attention to the implementation of product quality and health safety in the production process. GMP workshop is more than just hardware construction. GMP is a set of mandatory standards applicable to pharmaceutical, food, cosmetics, and other industries, requiring enterprises to meet the health and quality requirements in accordance with relevant national laws and regulations in terms of raw materials, personnel, facilities and equipment, production process, packaging and transportation, quality control, etc., and form a set of operable operating specifications to help enterprises improve the sanitary environment of enterprises and find problems in the production process in a timely manner to improve. Briefly, GMP requires pharmaceutical, food, cosmetics, and other manufacturers to have good production equipment, reasonable production processes, perfect quality management, and strict testing systems to ensure that the quality of final products meets regulatory requirements.
Lucius Pharma received a team of GMP professionals from Laos
On the morning of November 10, 2022, the morning sun was bright and transparent, everything was happy, the fog had dissipated, and the rising sun of the east sun shone rays of sunlight, sprinkling the entire Lucius Park. The tense expressions of all Lucius employees were swept away by the morning breeze, and it seemed that the whole park was soothed by this beautiful morning and fresh air.
On this day, the Lao government departments have the Ministry of Health, the Ministry of the Interior, the Ministry of Environment, and other officials to form a strong leadership team to visit Lucius Pharmaceutical Park to guide the work, accompanied by the chairman, CEO and other investors of Lucius Pharmaceutical to guide and inspect the work.
The seminar was mainly organized by the Food and Drug Administration, a department directly under the Ministry of Health, and the main health officials who participated included Dr. Ben Su, Director of the Food and Drug Administration, Dr. Su Lisha, Deputy Director, Dr. Su Songben, Deputy Director, Dr. Da Zhang, Director of the Drug Division, and Director of the Drug Testing Center.
The moment the expert group inspected the Lucius workshop
The members of the expert group put on special clothes for the clean workshop and conducted a strict visit and inspection of the GMP production workshop of Lucius Pharmaceutical! The inspection training lasted for two days!
Participants receive a certificate of completion
During the two-day GMP expert group, the members of the GMP expert group conducted professional training and the most rigorous inspection of Lucius Pharmaceutical and issued a training certificate to each of the participating production personnel who participated in the training and research, so that Lucius Pharmaceutical Group obtained the GMP inspection and testing evaluation at the national level in Laos. And obtained the GMP certification certificate from the Ministry of Health of the People's Republic of China.
Lucius Pharmaceutical (Laos) Co., Ltd. GMP Certification
Our efforts of all Lucius people will eventually have results, our Lucius Pharmaceutical will also develop and grow over time, the original intention of Lucius Pharmaceutical has always remained the same, our goal is to become the world's first-class generic drug company, quality first is our purpose, and it is our original intention to let the people below the global poverty line out of the sea of suffering!
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of Laos was in the spotlight for its outstanding performance. Their booth attracted a large audience and···【more】
Recommended:209Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appointed by the World Health Organization (WHO) and director of the Microbiology Laboratory of the Nationa···【more】
Recommended:223Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensive inspection of the Lucius Pharmaceutical factory in Laos. The results of this assessment are encou···【more】
Recommended:197Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in the pharmaceutical industry, Lucius Pharmaceutical was established in Vientiane, Laos in 2020, with a···【more】
Recommended:163Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has state-of-the-art facilities, including factories designed and constructed in strict accordance with ···【more】
Recommended:293Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea, Lucius Pharmaceuticals stands on the only Turkish Strait that connects the two seas, announcing Lu···【more】
Recommended:173Release date: 2024-07-09
As we all know, from the perspective of the universe, our solar system is very small, but from the perspective of the earth, it is very huge, the edge of the solar system is the Oo···【more】
Recommended:195Release date: 2024-07-09
At the beginning of May, Lucius Pharmaceutical (Laos) Co., Ltd. officially obtained the approval of the Ministry of Health of the People's Republic of China and launched 8 prod···【more】
Recommended:186Release date: 2024-07-09
The BRAF inhibitor known as Braftovi, manufactured by the French company pierre Fabre.What is the price of Braftovi per box? Where can it be purchased?Currently, there are two main···【more】
Recommended:263Release date: 2024-07-08
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more ab···【more】
Recommended:332Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and mortality, which has been troubling medical workers. Clinical studies have foun···【more】
Recommended:201Release date: 2024-07-09
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued favorable opinions, proposing an amendment to the mark···【more】
Recommended:158Release date: 2025-01-13
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced solid tumors, although further prospective research is still required. Historica···【more】
Recommended:156Release date: 2025-01-06
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administration (FDA) has given the green light to the first generic version of Victoza (···【more】
Recommended:171Release date: 2024-12-30
The new indication involves the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer with tumors with EGFR exon 19 deletion or exon 21 (L858R)···【more】
Recommended:161Release date: 2024-12-24
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combination with glucocorticoids (steroids) to help manage androgen (testosterone-like ···【more】
Recommended:146Release date: 2024-12-17
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, obecabtagene autoleucel, demonstrated a high res···【more】
Recommended:105Release date: 2024-12-13
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) gave a positive recommendation for the approval of toripalimab (brand name Lo···【more】
Recommended:248Release date: 2024-08-26
On June 27, 2024, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use issued a favorable opinion recommending the approval of a marketing autho···【more】
Recommended:191Release date: 2024-08-19
On August 2, 2024, the FDA granted accelerated approval to afamitresgene autoleucel, marking the first gene-engineered T-cell therapy approved for the treatment of solid tumors. Th···【more】
Recommended:207Release date: 2024-08-12
On June 14, 2024, the US Food and Drug Administration (FDA) granted approval for blinatumomab (Blincyto, Amgen Inc.) to be used in the consolidation phase of multiphase chemotherap···【more】
Recommended:207Release date: 2024-08-07
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all lung cancer cases. For patients with advanced or metastatic NSCLC, partic···【more】
Recommended:242Release date: 2024-08-05
On June 26, 2024, the Food and Drug Administration (FDA) granted accelerated approval to epcoritamab-bysp (Epkinly, Genmab US, Inc.), a bispecific CD20-directed CD3 T-cell engager,···【more】
Recommended:195Release date: 2024-08-01
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: